1. Home
  2. Bills
  3. H.R. 2820

H.R. 2820 · 114th Congress · 2015–2016

Stem Cell Therapeutic and Research Reauthorization Act of 2015

H.R. 2820 in the 114th Congress (2015–2016) became law — introduced on Jun 18, 2015, sponsored by Christopher H. Smith with 22 co-sponsors. Congress held 1 roll call vote on it.

During the 114th Congress (2015–2016), Barack Obama was president, and Republicans held majorities in both the House and Senate.

Status
Became law
Introduced
Jun 18, 2015
Co-sponsors
22
Policy area
Health
Public law
Public Law 114-104

What it does

Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Christopher H. Smith (R-NJ). Co-sponsors: 8 Democrats, 14 Republicans.

Where it stands

  • IntroducedJun 18, 2015
  • Passed the HouseSep 8, 2015
  • Passed the SenateDec 9, 2015
  • Sent to the PresidentDec 18, 2015
  • Became lawDec 18, 2015

Latest action: Became Public Law No: 114-104. (Dec 18, 2015)

How Congress voted

  • On Motion to Suspend the Rules and concur in the Senate Amendment
    House · Dec 16, 2015 · Passed
    421–0

Every roll call vote on this bill

More bills from Christopher H. Smith in the 114th Congress

Other Health bills in the 114th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 2820 (114th Congress): Stem Cell Therapeutic and Research…,” https://www.capitolreceipts.com/bill/114-hr-2820/stem-cell-therapeutic-and-research-reauthorization-act-of-2015 (accessed 2026-10-17).

Open the interactive version ›